New Study from UK’s Largest Virtual ADHD Service Validates Role of Objective Testing in Delivering Personalized, High-Quality Remote ADHD Care

Data presented at ADHD World Congress highlights how QbCheck supports diagnostic accuracy and individualized treatment monitoring, enabling efficient and robust care in virtual settings. News Summary: New findings show significant improvements in access, clinician confidence, symptom tracking, and individualized care using objective testing. The study underscores the importance of scalable, evidence-based tools, as many countries, … [Read more…]

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

ABCL575 is a novel, half-life extended anti-OX40L monoclonal antibody that is being developed for the treatment of moderate-to-severe atopic dermatitis (AD) In preclinical studies, ABCL575 shows potent inhibition of inflammatory pathways, favorable in vivo pharmacokinetics (PK), and potential for less frequent dosing compared to a clinical benchmark   VANCOUVER, British Columbia–(BUSINESS WIRE)–$ABCL—AbCellera (Nasdaq: ABCL) today … [Read more…]

Walgreens Committed to Supporting Rite Aid Customers and Employees

Walgreens is offering recruitment events for employees and no-hassle prescription transfers for customers impacted by Rite Aid transitions DEERFIELD, Ill.–(BUSINESS WIRE)–In light of Rite Aid’s recent bankruptcy filing, Walgreens is committed to assisting Rite Aid customers and employees who are impacted by store closures in their local community. For customers who want to transfer their … [Read more…]

Dr. Reddy’s Q4 & Full Year FY25 Financial Results

HYDERABAD, India–(BUSINESS WIRE)–$RDY #DRREDDY–Dr. Reddy’s Laboratories Ltd. (BSE: 500124 | NSE: DRREDDY | NYSE: RDY | NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and year ended March 31, 2025. The information mentioned in this release is based on consolidated financial statements under International Financial Reporting Standards (IFRS). Q4FY25 FY25   Revenues … [Read more…]

Pharma and Biotech Discovery Stage Partnering Terms and Agreements Analysis Report 2025 with Directory of 2,690 Deals Signed Since 2020 – Values, Upfronts, Milestones, and Royalty Structures – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Discovery Stage Partnering Terms and Agreements in Pharma and Biotech 2020-2025” report has been added to ResearchAndMarkets.com’s offering. This report contains a comprehensive listing of all discovery-stage partnering deals announced since 2020, including financial terms where available. It also features over 2,690 links to detailed online deal records, including publicly available contract documents … [Read more…]

GSK and Lifetime® launch original movie to raise awareness about the impact of meningitis

Pretty Hurts, a new Lifetime Original Movie brought to you by GSK, informs Lifetime’s mom audience about meningococcal disease, known as meningitis Partnership is part of GSK’s Ask2BSure campaign, which encourages parents of teens and young adults ages 16-23 to start a conversation with their teen’s doctor about meningitis and vaccination Hollywood moms of teens, … [Read more…]

Vir Biotechnology Announces Preliminary 24-Week Post-End of Treatment Data for Tobevibart and Elebsiran Combinations in Chronic Hepatitis B From the MARCH Study

HBsAg loss 24 weeks post-end of treatment achieved in 17% and 21% of participants with low baseline HBsAg receiving tobevibart + elebsiran without or with PEG-IFNα, respectively As previously announced, Phase 3 development in chronic hepatitis B to occur only with a global development and commercialization partner, which has not been secured Vir Biotechnology to … [Read more…]

AriBio Co., Ltd. and Fujirebio Diagnostics, Inc. Announce Completion of Sample Set for the Strategic Partnership Implemented to Advance Biomarker Development for Alzheimer’s Disease and Neurodegeneration

SAN DIEGO & TOKYO & MALVERN, Pa.–(BUSINESS WIRE)–Fujirebio Holdings Inc., its wholly-owned subsidiary Fujirebio Diagnostics, Inc., and AriBio Co., Ltd. announced the completion of a prospective sample acquisition as part of the strategic partnership to advance the development of biomarkers for Alzheimer’s disease and other neurodegenerative conditions. This milestone marks the fulfillment of AriBio’s commitment … [Read more…]

Afya Limited Announces First-Quarter 2025 Financial Results

Impressive Adjusted EBITDA Margin Expansion and Cash Generation Full Year 2025 Guidance Reaffirmed NOVA LIMA, Brazil–(BUSINESS WIRE)–Afya Limited (Nasdaq: AFYA; B3: A2FY34) (“Afya” or the “Company”), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three-month period ended March 31, 2025 (first quarter … [Read more…]

OneLegacy Continues to Expand Footprint with Offices in Mission Hills and Orange County

AZUSA, Calif.–(BUSINESS WIRE)–OneLegacy, the leading organ, eye, and tissue recovery organization serving seven counties in Southern California, is expanding with the opening of two new regional offices in Mission Hills and Orange County. This expansion marks a significant step in the organization’s mission to save and enhance lives through organ, eye, and tissue donation. By … [Read more…]